Pensionfund Dsm Netherlands Bristol Myers Squibb CO Transaction History

Pensionfund Dsm Netherlands

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$61.48 - $73.72 $1.97 Million - $2.36 Million	-32,000 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$59.17 - $69.31 $2.72 Million - $3.19 Million	-46,000 Reduced 58.97%	32,000 $1.89 Million
Q1 2021 Apr 01, 2021	BUY	$59.34 - $66.74 $178,020 - $200,219	3,000 Added 4.0%	78,000 $4.92 Million
Q1 2020 Apr 02, 2020	SELL	$46.4 - $67.43 $324,800 - $472,010	-7,000 Reduced 8.54%	75,000 $4.18 Million
Q4 2019 Jan 06, 2020	BUY	$49.21 - $64.19 $836,570 - $1.09 Million	17,000 Added 26.15%	82,000 $5.26 Million
Q3 2018 Oct 01, 2018	BUY	$55.19 - $62.25 $3.59 Million - $4.05 Million	65,000 New	65,000 $4.04 Million
Q1 2018 Apr 03, 2018	SELL	$59.92 - $68.98 $4.91 Million - $5.66 Million	-82,000 Closed	0 $0
Q4 2017 Jan 02, 2018	BUY	$59.94 - $65.35 $4.92 Million - $5.36 Million	82,000	82,000 $5.03 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Pensionfund Dsm Netherlands, based on Form 13F filings with the SEC.

Stay updated on Pensionfund Dsm Netherlands with notifications on news.